ExcepGen stands as the pioneering entity in the field of mRNA cellular interaction engineering. The company's unique platform possesses the capability to modify cellular responses to therapeutic mRNA. This alteration involves the suppression of undesirable cellular pathways while amplifying those deemed beneficial.